Search Menu Please donate You are here: Home Discover The coronavirus situation in England now The coronavirus situation in England now Waning immunity, boosters and where we are now Dr Elizabeth Webb examines the number of people in the country with coronavirus, the effectiveness of boosters and what we should be doing to continue the fight against the disease. By: Dr Elizabeth Webb Published: 4th November 2021 Over the last three months, the numbers of people with coronavirus in England have changed in a very unpredictable way: decreasing, then flattening off, increasing, and most recently decreasing again. Whether the numbers are going up or down, however, they have been reasonably high throughout. The Office for National Statistics publishes estimates each week of the number of people who have coronavirus, and since June this has been at least 1 in 100 people. During this last few months, older people have remained less likely than other age groups to have coronavirus, and the majority of infections have been among younger groups, particularly children, who have not yet had the opportunity to be vaccinated. The fact that around 95% of older people have had both first and second doses of the coronavirus vaccination has offered most older people excellent protection against catching and becoming ill with coronavirus. The most recent analysis from the ONS shows that unvaccinated people have been 32 times more likely to die of coronavirus this year than fully vaccinated people. Waning There is now evidence that the protection against catching coronavirus provided by both the Pfizer/BioNTech and Oxford/Astra-Zeneca coronavirus vaccinations gradually declines over time. However, protection against serious illness remains very high for at least 5 months, with evidence from Public Health England showing that Pfizer/BioNTech and Oxford/Astra-Zeneca provide 95% and 80% protection against hospitalisation, respectively, 5 months after the second jab. Although we don’t know much about how the protection from vaccination wanes over the longer term, there are concerns that the protection against hospitalisation may decrease. The Effectiveness of boosters There is now firm evidence that having a booster vaccination provides substantial additional protection against becoming ill with coronavirus, over and above the protection provided by the first two doses. Pfizer's clinical trial found that the booster provided 95.6% protection against becoming ill with coronavirus compared to just having two doses. Results of a study of the population of Israel – where they are further ahead in their vaccination programme than in England – found a similarly high level of protection from the boosters. What’s happening with boosters? Booster jabs started being administered in the middle of September, and since then nearly 7 million people in England have received a third coronavirus vaccine, with almost a quarter of a million people having one each day at this point. However, around 13 million people had their second jab 6 months or longer ago, suggesting that there are now around 6 million people in England who are eligible for but have not yet had their booster. What should I do? If you’ve not already been vaccinated against coronavirus, everyone over the age of 12 is now eligible to book, including those older people who haven’t yet taken up the opportunity. Anybody who had their second jab 6 months or longer ago is now eligible for a booster. People going for their first, second or booster vaccination can book on the NHS website or go to a walk-in clinic. You can now book your booster once it is 5 months since your second vaccination. For more information, read Age UK's information and advice. Antivirals This week we heard the news that the Medicines and Healthcare products Regulatory Agency (MHRA) has licenced an antiviral drug – molnupiravir – for use in the UK. The drug prevents the virus from multiplying in the body, so if given to someone in the early stages of illness with coronavirus can halve the chances of them becoming very unwell. The MHRA have said that the drug can be offered to older people aged 60 and older and other people at higher risk of severe illness from coronavirus. However, they are also clear that the drug isn’t a substitute for vaccination, which is more effective at preventing serious illness. Share this page Share on Facebook Tweet Print Last updated: Nov 11 2021 Become part of our story Facebook Twitter Youtube Instagram Sign up today Email address About Age UK What we do Work for us Age International Media / Press Latest news Who we are Services Age UK Advice Line Befriending services Charity shops In your area Popular pages Benefits Calculator TV licence concessions Pension Credit Making a will Latest The difference your support makes Fix care for good Save free TV for older people Support links Linking policy Terms and conditions Privacy policy Publications Cookies Safeguarding About us Sitemap Contact us Modern slavery statement Age UK, Tavis House, 1-6 Tavistock Square, London WC1H 9NA. Registered charity number 1128267. Company number 6825798. © Age UK Group and/or its National Partners (Age NI, Age Scotland and Age Cymru) 2021. All Rights Reserved Cookies on this website We use cookies to give you the best experience of our website. By clicking ‘accept cookies', you’re agreeing to our use of cookies. You can change this at any time. Accept All Cookies Change settings